An exploratory study on effects of visual cueing by wearable smart glasses to improve gait disturbance in patients with diseases involving basal ganglia
Phase 1
- Conditions
- diseases involving basal ganglia
- Registration Number
- JPRN-UMIN000022178
- Lead Sponsor
- Department of Neurology, The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with dementia (MMSE <= 21) 2) Patients with gait disturbance arising from causes other than extrapyramidal symptoms 3) Patients with severe visual impairment 4) Patients with severe depressive symptoms 5) When doctors decide that patients do not have eligibility for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method percent time frozen
- Secondary Outcome Measures
Name Time Method number of FOG(freezing of gait) events gait velocity time to initiate gait average stride length
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does visual cueing via wearable smart glasses modulate cortico-basal ganglia circuits in Parkinson's disease gait disorders?
What is the comparative efficacy of smart glass visual cueing versus standard physical therapy for Huntington's disease-related gait disturbances?
Which neuroimaging biomarkers correlate with improved gait outcomes in basal ganglia disease patients using wearable visual cueing?
What adverse events are associated with prolonged use of wearable smart glasses in basal ganglia disorder clinical trials?
How do visual cueing interventions synergize with dopaminergic medications in treating Parkinsonian gait abnormalities?